|
Elaprase (Idursulfase Solution for Infusion)
Manufactured by: Shire  This product requires a valid prescription
| |
|
Type |
Strength |
|
Quantity |
|
Price (USD) |
|
|
|
Elaprase (Idursulfase) is an enzyme replacement therapy from Shire Human Genetic Therapies.
Elaprase (Idursulfase) is designed to replace iduronate-2-sulfatase (I2S), the enzyme that is deficient or absent in people with Hunter syndrome.
Elaprase (Idursulfase) is a weekly infusion therapy, which means it is given intravenously (by IV).
Elaprase (Idursulfase) is designed to treat the underlying cause of Hunter syndrome by replacing the iduronate-2-sulfatase (I2S) enzyme which is deficient or absent in people with Hunter syndrome.
|
|
|
|
